Skip to main content

Recurrent Heart Failure and Appropriate Evaluation After Cardiac Resynchronization Therapy

  • Chapter
Devices for Cardiac Resynchronization
  • 657 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005;112:e154–235.

    Article  PubMed  Google Scholar 

  2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure. Lancet 1999;353:2001–7.

    Google Scholar 

  3. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303–10.

    Article  PubMed  CAS  Google Scholar 

  4. Pitt B, Zannad F, Remme WJ, et al for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709–717.

    Article  PubMed  CAS  Google Scholar 

  5. Reicin G, Miksic M, Yik A, Roman D. Hospital Supplies and Medical Technology 4Q05 Statistical Handbook: Growth Moderating But Outlook Remains Strong. New York: Morgan Stanley Equity Research North America; 2005:44.

    Google Scholar 

  6. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. Circulation 2002;106:2145–61.

    Article  PubMed  Google Scholar 

  7. Abraham WT, Fisher WG, Smith AL, Delurigic DB, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  8. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. JAMA 2003;289:2685–94.

    Article  PubMed  Google Scholar 

  9. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.

    Article  PubMed  CAS  Google Scholar 

  10. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–33.

    Article  PubMed  Google Scholar 

  11. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 2004;350:2140–50.

    Article  PubMed  CAS  Google Scholar 

  12. Cleland JGF, Daubert JC, Erdmann E, et al., for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352: 1539–49.

    Article  PubMed  CAS  Google Scholar 

  13. Saxon LA, DeMarco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization of echocardiographic measures of remodeling. Circulation 2002;105:1304–10.

    Article  PubMed  Google Scholar 

  14. Leclercq C, Kass DA. Retiming the failing heart: principle and clinical status of cardiac resyncrhonization. J Am Coll Cardiol 2002;39:194–201.

    Article  PubMed  Google Scholar 

  15. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 2004;43:1145–8.

    Article  PubMed  Google Scholar 

  16. Kass DA, Chan CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99;1567–73.

    Google Scholar 

  17. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825–31.

    Article  PubMed  CAS  Google Scholar 

  18. Packer M, Coats AJ, Fowler MB, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–8.

    Article  PubMed  CAS  Google Scholar 

  19. CIBIS-II Investigators and committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). Lancet 1999;353:9–13.

    Google Scholar 

  20. Wikstrand J, Hjalmarson A, Waagstein F, et al. MERIT-HF Study Group. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure. J Am Coll Cardiol 2002;40:491–8.

    Article  PubMed  CAS  Google Scholar 

  21. Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003;26:175–80.

    Article  PubMed  Google Scholar 

  22. Aranda JM Jr, Woo GW, Conti JB, Schofield RS, Conti CR, Hill JA. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol 2005;95:889–91.

    Article  PubMed  CAS  Google Scholar 

  23. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.

    Article  PubMed  CAS  Google Scholar 

  24. Aranda JM Jr., Woo GW, Schofield RS, et al. Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol 2005;46:2193–8.

    Article  Google Scholar 

  25. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258–63.

    Article  PubMed  Google Scholar 

  26. Breithardt OA, Sinha AM, Schwammenthal, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765–70.

    Article  PubMed  Google Scholar 

  27. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985–90.

    Article  PubMed  Google Scholar 

  28. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993–3001.

    PubMed  CAS  Google Scholar 

  29. Van Gelder BM, Bracke FA, Meijer A, et al. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 2004;93:1500–1503.

    Article  PubMed  Google Scholar 

  30. Leon AR, Abraham WT, Brozena S, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate to severe heart failure. J Am Coll Cardiol 2005;46:2298–304.

    Article  PubMed  Google Scholar 

  31. Bordachar P, Lafitte S, Reuter S, et al. Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. J Am Coll Cardiol 2004;44:2157–65.

    Article  PubMed  Google Scholar 

  32. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004:441834–40.

    Google Scholar 

  33. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615–22.

    Article  PubMed  Google Scholar 

  34. Adamson PB, Abraham WT, Love C, Reynolds D. The evolving challenge of chronic heart failure management: A call for a new curriculum for training heart failure specialists. J Am Coll Cardiol 2004;44:1354–7.

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Aranda, J.M. (2008). Recurrent Heart Failure and Appropriate Evaluation After Cardiac Resynchronization Therapy. In: Barold, S.S., Ritter, P. (eds) Devices for Cardiac Resynchronization. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71167-6_26

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-71167-6_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-71166-9

  • Online ISBN: 978-0-387-71167-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics